Loading data for FTH — first visit, this takes a few seconds.

Faeth Therapeutics, Inc. (FTH)

NasdaqCM: FTH · 即時價格 · USD

34.51

+1.74 (5.31%)

收盤價： Sep 02, 2026, 8:00 PM

39.37

+0.64%

盤後: 7:14 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

無可用資料

買價	31.8
市值	1.01B
營收 (ttm)	n/a
淨利（ttm）	-196M
	-0.31
	-60.86
	n/a
	-7.89
P/B (ttm)	5.84
P/S (ttm)	0.00
財報日期	Nov 3, 2026

賣價	34
成交量	276,713
20 日平均成交量	224,582
開盤價	33.44
前收盤價	32.77
當日區間	33.00 - 34.92
52 週範圍	7.45 - 37.90
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 FTH

Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The...

[閱讀更多]

產業 Biotechnology

類股 Healthcare

IPO 日期 Feb 4, 2021

員工 29

證券交易所 NasdaqCM

股票代號 FTH

網站 https://www.faeththerapeutics.com

完整的公司簡介

財務表現

Faeth Therapeutics 在 2025 年的營收為 0，較前一年的 0 增加 undefined%。淨利為 -21.09M，較前期減少 -30.08%。

財務報表

財報驚奇

Faeth Therapeutics 已於 Aug 4, 2026 公布季度財報：

營收為 $0 低於預期 $0, 年增 NaN% 成長.
每股盈餘為 -2.84 超出預期 1.92, 年增 27.37% 成長.

下次財報發布

Faeth Therapeutics, Inc. 的下次財報預計於 Nov 3, 2026, 開盤前。
分析師預估營收 ... 升級

價格為何變動

新聞動態

2 天前 · Zacks

What Makes Faeth Therapeutics, Inc. (FTH) a Strong Momentum Stock: Buy Now?

Does Faeth Therapeutics, Inc. (FTH) have what it takes to be a top stock pick for momentum investors? Let's find out.

1 週前 · Zacks

Wall Street Analysts Predict a 72.22% Upside in Faeth Therapeutics, Inc. (FTH): Here's What You Should Know

The mean of analysts' price targets for Faeth Therapeutics, Inc. (FTH) points to a 72.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreemen...